Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | LPE(20:3) | Lipid-depleted/compactin | 0.0 | BCD100322A02 | 68 | pmol/sample |
| - | LPE(20:3) | Lipid-depleted/compactin | 0.5 | BCD100322A05 | 67.6 | pmol/sample |
| - | LPE(20:3) | Lipid-depleted/compactin | 1.0 | BCD100322A09 | 53 | pmol/sample |
| - | LPE(20:3) | Lipid-depleted/compactin | 2.0 | BCD100322A13 | 238 | pmol/sample |
| - | LPE(20:3) | Lipid-depleted/compactin | 4.0 | BCD100322A17 | 311 | pmol/sample |
| - | LPE(20:3) | Lipid-depleted/compactin | 8.0 | BCD100322A21 | 361 | pmol/sample |
| - | LPE(20:3) | Lipid-depleted/compactin | 12.0 | BCD100322A25 | 84.4 | pmol/sample |
| - | LPE(20:3) | Lipid-depleted/compactin | 24.0 | BCD100322A29 | 124 | pmol/sample |
| - | LPE(20:3) | C | 0.0 | BCD100322A01 | 77 | pmol/sample |
| - | LPE(20:3) | C | 0.5 | BCD100322A03 | 60.2 | pmol/sample |
| - | LPE(20:3) | C | 1.0 | BCD100322A07 | 82.2 | pmol/sample |
| - | LPE(20:3) | C | 2.0 | BCD100322A11 | 69.4 | pmol/sample |
| - | LPE(20:3) | C | 4.0 | BCD100322A15 | 180 | pmol/sample |
| - | LPE(20:3) | C | 8.0 | BCD100322A19 | 329 | pmol/sample |
| - | LPE(20:3) | C | 12.0 | BCD100322A23 | 356 | pmol/sample |
| - | LPE(20:3) | C | 24.0 | BCD100322A27 | 115 | pmol/sample |
| - | LPE(20:3) | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100322A06 | 77.2 | pmol/sample |
| - | LPE(20:3) | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100322A10 | 100 | pmol/sample |
| - | LPE(20:3) | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100322A14 | 186 | pmol/sample |
| - | LPE(20:3) | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100322A18 | 274 | pmol/sample |
| - | LPE(20:3) | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100322A22 | 367 | pmol/sample |
| - | LPE(20:3) | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100322A26 | 94 | pmol/sample |
| - | LPE(20:3) | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100322A30 | 107 | pmol/sample |
| - | LPE(20:3) | 25OH-Chol | 0.5 | BCD100322A04 | 63.9 | pmol/sample |
| - | LPE(20:3) | 25OH-Chol | 1.0 | BCD100322A08 | 84 | pmol/sample |
| - | LPE(20:3) | 25OH-Chol | 2.0 | BCD100322A12 | 110 | pmol/sample |
| - | LPE(20:3) | 25OH-Chol | 4.0 | BCD100322A16 | 257 | pmol/sample |
| - | LPE(20:3) | 25OH-Chol | 8.0 | BCD100322A20 | 429 | pmol/sample |
| - | LPE(20:3) | 25OH-Chol | 12.0 | BCD100322A24 | 317 | pmol/sample |
| - | LPE(20:3) | 25OH-Chol | 24.0 | BCD100322A28 | 141 | pmol/sample |